AbbVie Biotherapeutics Inc.;Dana-Farber Cancer Institute, Inc.
发明人:
Afar, Daniel,Andersen, Kenneth C.,Tai, Yu-Tzu
申请号:
LT13168383
公开号:
LT2641601T
申请日:
2007.08.07
申请国别(地区):
LT
年份:
2016
代理人:
摘要:
Composition suitable for treating multiple myeloma in a subject, comprising a therapeutically effective amount of HuLuc63, a therapeutically effective amount of bortezomib, and a pharmaceutically acceptable carrier, wherein said composition is capable of being administered in a single or multiple dose regimen.